Medical Equipment Reimbursement Market Outlook (2022-2032)
[250 Pages Report] Newly released Medical Equipment Reimbursement Market analysis report by Future Market Insights shows that global sales of the Medical Equipment Reimbursement Market in 2021 were held at US$ 414.1 Million.With 12.9%, theprojectedmarketgrowthduring2022 to 2032 is expected to be significantly higher than the historical growth.
Private is expected to be the highest revenue-generating Payer, projected to grow at a CAGR of over 12.9% during 2022 to 2032.
Attributes
Details
Medical Equipment Reimbursement Market CAGR (2022 to 2032)
12.9%
Medical Equipment Reimbursement Market Size (2022)
US$ 464.2 Million
Medical Equipment Reimbursement Market Size (2032)
US$ 1.5 Billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue Of Medical Equipment Reimbursement Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032
As per the Medical Equipment Reimbursement Market research by Future Market Insights - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Medical Equipment Reimbursement Market increased at around 11.1% CAGR.
Medical device reimbursements are made to a healthcare provider by third parties, such as private or public health insurers, for expenses incurred while using the medical equipment. The market growth is being driven by a growing reliance on reimbursement, the surge in the prevalence of chronic diseases, and an increase in preventative care.
The focus on early diagnosis and preventative treatment may lead to increased activity in the diagnostic equipment market, resulting in increased reimbursement share. For example, in developed economies, breast cancer screening, a fundamental paradigm change toward rewarding early diagnosis through payment has been observed.
With the rising need for healthcare equipment, remuneration services are likely to present a plethora of opportunities for the healthcare industry to take advantage of. In addition, the market is being fuelled by an increase in the number of people seeking insurance and the consolidation of the healthcare system.
What Factors Are Propelling Medical Equipment Reimbursement Demand?
Over the projected period, the global Medical Equipment Reimbursementmarket is expected to develop due to an increase in the number of chronic diseases and their preventive care. Increased attention to early diagnosis and preventative treatment may lead to increased activity in the diagnostic device business, resulting in a higher remuneration share.
For example, in developed countries, such as breast cancer screening, a major paradigm change toward promoting early diagnosis through remuneration has been observed.
An increasing patient population, more awareness of insurance policies, and rising healthcare costs are all factors that are boosting the market expansion for medical device reimbursement.
The Medical Equipment Reimbursement market is on the surge due to the growing occurrence of prolonged diseases such as diabetes, cardiovascular diseases (CVD), and others. Diabetes affects roughly 422 Mn people globally, a large proportion of whom are from low-income countries.
Furthermore, diabetes kills another 1.6 Mn people each year, according to the World Health Organization (WHO). Additionally, during the forecast period 2022-2032, an increase in healthcare prices is expected to boost the Medical Equipment Reimbursement market's growth.
Aditya Birla Health Insurance Company Ltd., for example, launched a campaign named "ABHI Karo" to raise public awareness about health insurance. The surging healthcare cost, coupled with supportive government policies, has been adding to the number of people who choose payer services, thus propelling the demand for medical device reimbursement from 2022 to 2032.
Find your sweet spots for generating winning opportunities in this market.
Which Industries Pulled The Growth Trigger In Medical Equipment Reimbursement Market?
Reimbursement of medical devices is gaining popularity in the insurance industry. In the United States alone, the healthcare payment system is intricate, and reimbursement details vary from one country to the next. It would be a good idea to become familiar with your reimbursement possibilities ahead of time.
In time, the health system will demand more and more devices, which will present a steep rise in the reimbursement industry. Along with demographic developments, this will be a major factor in the requirement for medical care expenditures. Other factors contributing to the rapid development of the industry are the cost of healthcare, the ever-expanding patient population, as well as growing awareness about health insurance policies.
Private and public payer services are included in the payer services section. Due to factors such as rising demand for improved treatment and the rising prevalence of diabetes and cancer, the private segment is likely to rise at a fast pace throughout the forecast period.
The global Medical Equipment Reimbursement market has been divided into outpatient facilities, hospitals, and other healthcare settings. Due to reasons such as the increased frequency of chronic diseases and the growing older population, the hospital segment is likely to grow at a profitable rate over the forecast period.
A determination of reimbursement is made from one or the other of two sources as a payment for clothes or accessories that are worn to support or in treating a medical condition, or as a payment for a continuous time during which surgery comprising a surgical device or medical instrument was performed. Medical coding and electronic medical record (EMR) use are common in used care providers.
Region-Wise Analysis
Which Region is projected to Offer the Largest Opportunity for Medical Equipment Reimbursement Market?
North America dominated the medical device reimbursement market in 2021, accounting for 50% of total revenue, and is likely to continue to do so throughout the forecast period. Over the forecast period, rising cases of numerous severe diseases are expected to boost the market.
Furthermore, as compared to other locations in the region, the reimbursement framework is the most advanced. Committees revise the list of devices every two years to ensure that the most recent products are included in the reimbursement scheme.
The need for medical device reimbursement is projected to rise as regulatory conditions change and pressure on the healthcare business to reduce service costs grows. As a result, the market is likely to grow throughout the forecast period.
In Europe, the market is likely to be driven by an increase in the number of healthcare centers and increased demand for medical equipment. However, rising healthcare expenditure, rising chronic disease prevalence, and rising resource demand in developing countries like China, Japan, South Korea, and India are expected to drive considerable growth in the Asia Pacific throughout the projection period.
In order to streamline and establish a highly efficient healthcare management system, these countries are implementing policies similar to those used in the United States and Europe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-Wise Analysis
Which Country Lies at the Center Stage for Medical Equipment Reimbursement Market Revenue?
The United States is expected to have the highest market share of US$ 609.1 Mn by the end of 2032 with North America being the dominant player and accounting for 50% of the total sales. The healthcare supplier community might see more demand for healthcare reimbursers and more significant comprehension of the ways it can become more expensive. Additionally, it is more likely to encourage healthcare centers.
The rise in the volume of chronic diseases is spurring demand for a range of healthcare devices. Since the advent of the coronavirus pandemic, the medical device industry has been negatively impacted, but demand for homecare medical equipment has increased. This has a positive influence on remote monitoring devices, wearable devices, home infusion equipment, and durable healthcare instruments reimbursement coverage.
Increased reimbursement for medical devices will spur technological breakthroughs by medical device manufacturers. In the long run, this will result in greater healthcare outcomes and cost-efficiency. In order to boost their profit margins, medical device companies are also spending on consulting for the drafting of appropriate reimbursement submissions for regulatory bodies.
This trend is predicted to continue, as reimbursement remains as the hurdle for medical device manufacturers to overcome in order to gain coverage and attract risk-averse investors.
Since the passage of the Affordable Care Act, the healthcare industry in North America, has shifted from a volume-based to a value-based care model, fueling the demand for reimbursement consulting.
Category-Wise Insights
Why do Private Payers stand as the Most Potential Revenue Source for Medical Equipment Reimbursement?
Revenue through the private payers category is forecasted to grow at the highest CAGR of over 12.8% during 2022-2032. The medical technology industry had the highest sales ratio of over 65% in 2021 over all other market segments. A large number of new businesses contributed to this sector's growth.
The revenue category is projected to hold its prominence in the marketplace over the long-term forecast. In addition, the reimbursement criteria presently reflect the purchase price of a product or a treatment, not the value of the technology used. Using the lower average reimbursement, advanced technology medical devices are not commonly available in public health systems.
The rising rate of public payers which serve both emerging and developed regions, combined with increased medical innovation, are exposing increasingly demanding clients in the public medical device reimbursement field.
Around 8.5 million non-urgent patients were treated in the UK by the NHS in 2017, while around 135,000 people were provided with long-term medical care. As a result, the tech industry is likely to trend up over the course of the next 5 to 10 years, as the aged population increases and chronic illnesses become more common.
Which Healthcare Setting of Medical Equipment Reimbursement is expected to Score Highest Growth in the Coming Years?
The Hospitals segment is forecasted to grow at the highest CAGR of over 14.3% during 2022-2032. The Hospitals sector holds the largest market share. In 2021, the hospital setting accounted for the largest market share of 53.5%. The segment is likely to maintain its dominance over the projected period.
Furthermore, the segment is being driven by an aging population and an increase in the prevalence of chronic diseases. The increased prevalence of chronic illnesses is driving up demand for medical device reimbursement in large-scale settings such as hospitals. Over the forecast period, the outpatient facilities category is expected to increase at a fast pace of 11.8%.
What was the impact of Covid-19 on the Medical Equipment Reimbursement Market?
COVID-19 resulted in an increase in market demand for home-based care services, which is expected to have a beneficial impact on reimbursement coverage for remote monitoring, durable medical devices, and home infusion devices. During the COVID-19 pandemic, the National Association for Home Care and Hospice, as well as the ALS Association, have asked CMS for a 1,135 blanket waiver, which would cover all infusion therapy.
Competitive Analysis
Among the leading players in the global Medical Equipment Reimbursement market are UnitedHealth Group, Aetna, Cigna, Humana, and Allianz. To streamline and establish an effective healthcare system, these companies are applying policies that are already in place in wealthy countries.
Medical Equipment Reimbursement Market Report Scope
Attributes
Details
Forecast Period
2022 to 2032
Historical Data Available for
2017 to 2021
Market Analysis
US$ Billion for Value
Key Regions Covered
North America, Europe, Latin America, APAC, Middle East & Africa
Key Countries Covered
United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, South Korea, Japan, India, Australia
Key Market Segments Covered
Payer, Healthcare Setting, Region
Key Companies Profiled
United Health Group
Aetna
Cigna
Humana
Allianz
Aviva
Nippon Life Insurance
CVS Health
Wellcare Health Plans
BNP Paribas
Pricing
Available upon Request
Market Segments Covered In Medical Equipment Reimbursement Market Analysis
By Payer Type:
Public
Private
By Healthcare Setting:
Hospitals
Outpatient Facilities
Other Healthcare Settings
By Region:
North America
Latin America
Europe
APAC
Middle East and Africa
Frequently Asked Questions
How much is the current worth of the Medical Equipment Reimbursement Market?
The global Medical Equipment Reimbursement market is worth more than US$ 414.1 Mn at present.
What is the sales forecast for Medical Equipment Reimbursement Market?
The value of Medical Devices are projected to increase at a CAGR of around 12.9% during 2022 – 2032.
What was the last 5 year’s market CAGR?
The value of the Medical Equipment Reimbursement Market increased at a CAGR of around 11.1% during 2017 – 2021.
What is a key trend shaping the growth of the market for Medical Equipment Reimbursement Market?
Over time, a growing aging population and rising healthcare costs will almost certainly increase. An increasing patient population, surge in awareness about insurance policies, and rising healthcare costs are boosting the market expansion for medical device reimbursement.
At what percentage is sales of Medical Equipment Reimbursement Market going to register growth in the US?
The market for Medical Equipment Reimbursement Market in the US is projected to expand at a CAGR of around 12% during 2022 – 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Payer
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Payer, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Payer, 2022-2032
5.3.1. Public Payers
5.3.2. Private Payers
5.4. Y-o-Y Growth Trend Analysis By Payer, 2017-2021
5.5. Absolute $ Opportunity Analysis By Payer, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Healthcare Setting
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Healthcare Setting, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Healthcare Setting, 2022-2032
6.3.1. Hospitals
6.3.2. Outpatient Facilities
6.3.3. Other Healthcare Settings
6.4. Y-o-Y Growth Trend Analysis By Healthcare Setting, 2017-2021
6.5. Absolute $ Opportunity Analysis By Healthcare Setting, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Payer
8.2.3. By Healthcare Setting
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Payer
8.3.3. By Healthcare Setting
8.4. Key Takeaways
9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Payer
9.2.3. By Healthcare Setting
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Payer
9.3.3. By Healthcare Setting
9.4. Key Takeaways
10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Payer
10.2.3. By Healthcare Setting
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Payer
10.3.3. By Healthcare Setting
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Rest of Asia Pacific
11.2.2. By Payer
11.2.3. By Healthcare Setting
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Payer
11.3.3. By Healthcare Setting
11.4. Key Takeaways
12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC
12.2.1.2. Rest of MEA
12.2.2. By Payer
12.2.3. By Healthcare Setting
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Payer
12.3.3. By Healthcare Setting
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Payer
13.1.2.2. By Healthcare Setting
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Payer
13.2.2.2. By Healthcare Setting
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Payer
13.3.2.2. By Healthcare Setting
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Payer
13.4.2.2. By Healthcare Setting
13.5. Argentina
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Payer
13.5.2.2. By Healthcare Setting
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Payer
13.6.2.2. By Healthcare Setting
13.7. Italy
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Payer
13.7.2.2. By Healthcare Setting
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Payer
13.8.2.2. By Healthcare Setting
13.9. U.K.
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Payer
13.9.2.2. By Healthcare Setting
13.10. Spain
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Payer
13.10.2.2. By Healthcare Setting
13.11. Russia
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Payer
13.11.2.2. By Healthcare Setting
13.12. BENELUX
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Payer
13.12.2.2. By Healthcare Setting
13.13. China
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Payer
13.13.2.2. By Healthcare Setting
13.14. Japan
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Payer
13.14.2.2. By Healthcare Setting
13.15. South Korea
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Payer
13.15.2.2. By Healthcare Setting
13.16. India
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Payer
13.16.2.2. By Healthcare Setting
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Payer
13.17.2.2. By Healthcare Setting
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Payer
14.3.3. By Healthcare Setting
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Value (US$ Mn)ed Health Group
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segment
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.2. Aetna
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segment
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.3. Cigna
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segment
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.4. Humana
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segment
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.5. Allianz
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segment
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.6. Aviva
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segment
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.7. Nippon Life Insurance
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segment
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.8. CVS Health
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segment
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.9. Wellcare Health Plans
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segment
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.10. BNP Paribas
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segment
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Table 04: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 05: North America Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 06: North America Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Table 07: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 08: Latin America Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 09: Latin America Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 12: Europe Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: MEA Market Value (US$ Mn) Forecast by Payer, 2017-2032
Table 18: MEA Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Value (US$ Mn) by Payer, 2022-2032
Figure 02: Global Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 03: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 04: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 07: Global Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 08: Global Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 09: Global Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 10: Global Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 11: Global Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 13: Global Market Attractiveness by Payer, 2022-2032
Figure 14: Global Market Attractiveness by Healthcare Setting, 2022-2032
Figure 15: Global Market Attractiveness by Region, 2022-2032
Figure 16: North America Market Value (US$ Mn) by Payer, 2022-2032
Figure 17: North America Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 28: North America Market Attractiveness by Payer, 2022-2032
Figure 29: North America Market Attractiveness by Healthcare Setting, 2022-2032
Figure 30: North America Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Market Value (US$ Mn) by Payer, 2022-2032
Figure 32: Latin America Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 40: Latin America Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 43: Latin America Market Attractiveness by Payer, 2022-2032
Figure 44: Latin America Market Attractiveness by Healthcare Setting, 2022-2032
Figure 45: Latin America Market Attractiveness by Country, 2022-2032
Figure 46: Europe Market Value (US$ Mn) by Payer, 2022-2032
Figure 47: Europe Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 55: Europe Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 58: Europe Market Attractiveness by Payer, 2022-2032
Figure 59: Europe Market Attractiveness by Healthcare Setting, 2022-2032
Figure 60: Europe Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Market Value (US$ Mn) by Payer, 2022-2032
Figure 62: Asia Pacific Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 73: Asia Pacific Market Attractiveness by Payer, 2022-2032
Figure 74: Asia Pacific Market Attractiveness by Healthcare Setting, 2022-2032
Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032
Figure 76: MEA Market Value (US$ Mn) by Payer, 2022-2032
Figure 77: MEA Market Value (US$ Mn) by Healthcare Setting, 2022-2032
Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Market Value (US$ Mn) Analysis by Payer, 2017-2032
Figure 83: MEA Market Value Share (%) and BPS Analysis by Payer, 2022-2032
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Payer, 2022-2032
Figure 85: MEA Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032
Figure 86: MEA Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032
Figure 87: MEA Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032
Figure 88: MEA Market Attractiveness by Payer, 2022-2032
Figure 89: MEA Market Attractiveness by Healthcare Setting, 2022-2032
Figure 90: MEA Market Attractiveness by Country, 2022-2032
